BGI Genomics Co., Ltd.
300676.SZ
Price:
$45.56
Market Cap:
$19.06B
BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its servi...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-07-14
Stock Exchange
SHZ
Ticker
300676.SZ
PE Ratio
[-23.48]
ROE
[-8.71%]
Current Ratio
[2.81]
Dividend Yield
[0%]
Enterprise Value
[16.58B]
Dividend History
The ROE as of December 2025 (TTM) for BGI Genomics Co., Ltd. (300676.SZ) is -8.71%
According to BGI Genomics Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -8.71%. This represents a change of 297.59% compared to the average of -2.19% of the last 4 quarters.
BGI Genomics Co., Ltd. (300676.SZ) Historical ROE (quarterly & annually)
How has 300676.SZ ROE performed in the past?
The mean historical ROE of BGI Genomics Co., Ltd. over the last ten years is 9.37%. The current -8.71% ROE has changed -192.93% with respect to the historical average. Over the past ten years (40 quarters), 300676.SZ's ROE was at its highest in in the June 2020 quarter at 27.08%. The ROE was at its lowest in in the December 2020 quarter at -10.41%.
Average
9.37%
Median
8.88%
Minimum
-9.88%
Maximum
35.37%
BGI Genomics Co., Ltd. (300676.SZ) ROE by Quarter and Year
Discovering the peaks and valleys of BGI Genomics Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 452.16%
Maximum Annual ROE = 35.37%
Minimum Annual Increase = -1148.73%
Minimum Annual ROE = -9.88%
| Year | ROE | Change |
|---|---|---|
| 2024 | -9.88% | -1148.73% |
| 2023 | 0.94% | -88.17% |
| 2022 | 7.97% | -49.22% |
| 2021 | 15.68% | -55.65% |
| 2020 | 35.37% | 452.16% |
| 2019 | 6.41% | -31.00% |
| 2018 | 9.28% | -3.26% |
| 2017 | 9.60% | -3.09% |
| 2016 | 9.90% | 16.93% |
| 2015 | 8.47% | 257.14% |
BGI Genomics Co., Ltd. (300676.SZ) Average ROE
How has 300676.SZ ROE performed in the past?
The current ROE of BGI Genomics Co., Ltd. (300676.SZ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.32%
5-year avg
10.02%
10-year avg
9.37%
BGI Genomics Co., Ltd. (300676.SZ) ROE vs. Peers
How is 300676.SZ’s ROE compared to its peers?
BGI Genomics Co., Ltd.’s ROE is less than Autobio Diagnostics Co., Ltd. (12.66%), greater than Guangzhou Kingmed Diagnostics Group Co., Ltd. (-7.96%), greater than Winning Health Technology Group Co., Ltd. (-5.22%), less than DaShenLin Pharmaceutical Group Co., Ltd. (15.79%), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (14.47%), less than Double Medical Technology Inc. (16.99%), less than Shenyang Xingqi Pharmaceutical Co.,Ltd (37.18%), less than Topchoice Medical Corporation (12.35%), greater than Mabwell (Shanghai) Bioscience Co., Ltd. (-85.64%), less than iRay Technology Company Limited (10.72%),
| Company | ROE | Market cap |
|---|---|---|
| 12.66% | $20.55B | |
| -7.96% | $13.07B | |
| -5.22% | $19.64B | |
| 15.79% | $20.59B | |
| 14.47% | $19.07B | |
| 16.99% | $20.15B | |
| 37.18% | $16.86B | |
| 12.35% | $18.35B | |
| -85.64% | $15.71B | |
| 10.72% | $21.06B |
Build a custom stock screener for BGI Genomics Co., Ltd. (300676.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BGI Genomics Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BGI Genomics Co., Ltd. (300676.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BGI Genomics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is BGI Genomics Co., Ltd.'s ROE?
How is the ROE calculated for BGI Genomics Co., Ltd. (300676.SZ)?
What is the highest ROE for BGI Genomics Co., Ltd. (300676.SZ)?
What is the 3-year average ROE for BGI Genomics Co., Ltd. (300676.SZ)?
What is the 5-year average ROE for BGI Genomics Co., Ltd. (300676.SZ)?
How does the current ROE for BGI Genomics Co., Ltd. (300676.SZ) compare to its historical average?